Literature DB >> 28188478

Calculating the incalculable. Optimal radioiodine dose in Graves' hyperthyroidism.

Laszlo Hegedüs1, Steen J Bonnema2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28188478     DOI: 10.1007/s12020-017-1253-1

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  7 in total

1.  A randomized comparison of radioiodine doses in Graves' hyperthyroidism.

Authors:  William D Leslie; Linda Ward; Elizabeth A Salamon; Sora Ludwig; Richard C Rowe; Elizabeth A Cowden
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

2.  Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials.

Authors:  Martin A Walter; Matthias Briel; Mirjam Christ-Crain; Steen J Bonnema; John Connell; David S Cooper; Heiner C Bucher; Jan Müller-Brand; Beat Müller
Journal:  BMJ       Date:  2007-02-19

Review 3.  Graves' Disease.

Authors:  Terry J Smith; Laszlo Hegedüs
Journal:  N Engl J Med       Date:  2016-10-20       Impact factor: 91.245

4.  2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis.

Authors:  Douglas S Ross; Henry B Burch; David S Cooper; M Carol Greenlee; Peter Laurberg; Ana Luiza Maia; Scott A Rivkees; Mary Samuels; Julie Ann Sosa; Marius N Stan; Martin A Walter
Journal:  Thyroid       Date:  2016-10       Impact factor: 6.568

Review 5.  Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome.

Authors:  Steen Joop Bonnema; Laszlo Hegedüs
Journal:  Endocr Rev       Date:  2012-09-07       Impact factor: 19.871

6.  Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while?

Authors:  A E Jarløv; L Hegedüs; L O Kristensen; B Nygaard; J M Hansen
Journal:  Clin Endocrinol (Oxf)       Date:  1995-09       Impact factor: 3.478

7.  Calculation of therapeutic activity of radioiodine in Graves' disease by means of Marinelli's formula, using technetium (99mTc) scintigraphy.

Authors:  Piotr Szumowski; Małgorzata Mojsak; Saeid Abdelrazek; Monika Sykała; Anna Amelian-Fiłonowicz; Dorota Jurgilewicz; Janusz Myśliwiec
Journal:  Endocrine       Date:  2016-08-24       Impact factor: 3.633

  7 in total
  1 in total

1.  [Role and effectiveness of radioactive-iodine therapy for the treatment of Grave's disease].

Authors:  Ali Sellem; Wassim Elajmi; Rania Ben Mhamed; Nesrine Oueslati; Haroun Ouertani; Hatem Hammami
Journal:  Pan Afr Med J       Date:  2020-08-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.